For collaborators/clients who are interested in the scientific, policy, and management aspects of clinical trials.
Services include:
- Study design
- Treatment allocation
- Randomization and stratification
- Quality control
- Sample size requirements
- Patient consent
- Statistical analysis
- Interpretation of results
Additional consultation can be provided in the areas of matching imaging modalities to drug mechanism-of-action, evaluating strategic decisions (signs of drug bioactivity, go/no-go decisions), and advice on the acceptability of specific imaging endpoints by regulatory agencies.



